Foxj3 binds DNA through its forkhead domain, with distinct binding preferences compared to other FOX proteins:
Core Motif: GTAAACA consensus sequence, but Foxj3 exhibits relaxed specificity in flanking regions .
Chromatin Context: Co-occupies regions marked by H3K18ac (active regulatory elements) when bound with FOXK2 and FOXO3 .
Comparative Binding:
| FOX Protein | Binding Motif | Key Chromatin Feature |
|---|---|---|
| FOXJ3 | GTAAACA (relaxed flanks) | H3K18ac in shared regions |
| FOXK2 | GTAAACA (5′ flanks) | Triply bound regions |
| FOXO3 | GTAAACA (core-only) | Shared with FOXJ3 |
Foxj3 regulates diverse cellular processes and is implicated in cancer:
Recombinant Foxj3 is used in molecular studies to analyze its interactions and functional roles:
Antibodies:
Experimental Protocols:
| Antibody | Application | Dilution | Reactivity |
|---|---|---|---|
| AF5786 | Western Blot | 1 µg/mL | Human/Mouse |
| 19751-1-AP | Western Blot | 1:500–1:3000 | Human/Mouse |
Post-translational modifications modulate Foxj3’s activity:
S223 Phosphorylation:
T216 Phosphorylation:
Mechanistic Impact: Phosphorylation may alter DNA-binding affinity or protein interactions, influencing target gene expression .
Foxj3 serves as a potential biomarker in oncology:
Note: We will prioritize shipping the format currently in stock. If you require a specific format, please specify this during order placement.
Note: Our proteins are shipped with standard blue ice packs. Dry ice shipping is available upon request but will incur additional charges. Please contact us in advance to arrange this.
The tag type will be determined during production. If you have a specific tag requirement, please inform us, and we will prioritize its development.
Forkhead box protein J3 (FOXJ3) is a transcriptional activator of MEF2C, playing a crucial role in regulating adult muscle fiber type identity and skeletal muscle regeneration. It also has a significant role in spermatogenesis, being essential for spermatogonia survival and participating in spermatocyte meiosis.
Mouse FOXJ3 is a member of the forkhead box (Fox) family of transcription factors, characterized by a conserved DNA-binding domain called the forkhead domain. The protein contains approximately 622 amino acids and functions primarily as a transcriptional regulator. FOXJ3 contains a forkhead DNA binding region and phosphorylation sites, notably at Ser223 and T216, which play critical roles in its regulatory function .
Western blot analysis shows that FOXJ3 is detected as a band of approximately 80 kDa in nuclear extracts . The protein structure analysis indicates that FOXJ3 binds to DNA through its forkhead domain, which adopts a winged-helix conformation similar to other FOX proteins .
FOXJ3 demonstrates tissue-specific expression patterns, with particularly high expression observed in:
Expression analysis using conditional knockout models has shown that FOXJ3 expression is temporally regulated during development, with critical expression periods during early postnatal development, especially in reproductive and muscle tissues .
FOXJ3 regulates multiple genes involved in various biological processes:
Transcriptional assays in C2C12 myoblasts demonstrated that FOXJ3 activates the Mef2c gene in a dose-dependent manner through binding to a conserved forkhead binding site .
Several distinct phenotypes have been observed in FOXJ3 knockout models:
Muscle-specific effects: FOXJ3 mutant mice have significantly fewer Type I slow-twitch myofibers and impaired skeletal muscle contractile function compared to wild-type controls. Following severe injury, they demonstrate impaired muscle regeneration .
Reproductive phenotypes:
Cellular phenotypes:
Recombinant mouse FOXJ3 can be generated using several approaches:
E. coli expression system:
Clone the mouse FOXJ3 cDNA (full-length or specific domains) into a bacterial expression vector with appropriate tags (His-tag is commonly used)
Express in E. coli Rosetta (DE3) strain at optimized conditions
Purify using affinity chromatography and validate using Western blot with anti-FOXJ3 antibodies
Validation methods:
Western blot analysis using specific antibodies against FOXJ3 or epitope tags
DNA binding assays to confirm functionality (electrophoretic mobility shift assay or chromatin immunoprecipitation)
Transcriptional activation assays using reporter constructs containing FOXJ3 binding sites
For optimal activity, consider using the RBR-forkhead domains (rather than forkhead domain alone), as studies have shown that the linker region (RBR) is important for proper folding and DNA binding specificity .
Several complementary approaches can be used to study FOXJ3 DNA binding specificity:
Chromatin Immunoprecipitation (ChIP):
In vitro DNA binding assays:
Electrophoretic mobility shift assays (EMSA) with recombinant FOXJ3 protein and labeled DNA probes
DNA footprinting to identify protected regions
Surface plasmon resonance (SPR) to measure binding kinetics
Specialized functional analysis:
Research has shown that FOXJ3 RBR-forkhead construct demonstrates different DNA binding preferences compared to the forkhead domain alone, highlighting the importance of the linker region for proper DNA recognition .
FOXJ3 plays critical roles in muscle biology through several mechanisms:
Myofiber type determination:
Transcriptional regulation:
Muscle regeneration:
The transcriptional activation of Mef2c by FOXJ3 appears to be dose-dependent and requires binding to the conserved FBS in the enhancer region .
FOXJ3 has stage-specific roles in male germ cell development, as demonstrated by conditional knockout mouse models:
Role in spermatogonia survival:
Role in meiotic progression:
These distinct phenotypes highlight FOXJ3's dual role in both pre-meiotic germ cell survival and the proper execution of meiotic processes.
FOXJ3 functions within complex transcriptional networks alongside other FOX family members:
Overlapping genomic binding sites:
Differential binding preferences:
Despite sharing core consensus motifs, FOX proteins show differences in flanking sequence preferences
FOXJ3 and FOXO3 preferentially bind to a variant of the consensus GTAAACA motif that incorporates two A residues preceding the TAAACA sequence
These subtle differences contribute to gene-specific regulation
Functional consequences:
Regions bound by multiple FOX proteins (FOXK2/FOXO3/FOXJ3) show higher FOX protein occupancy
These regions are enriched for the histone acetylation mark H3K18ac, suggesting active regulatory status
Genes associated with these multiply-bound regions are enriched for important biological processes including apoptotic signaling
This indicates that FOX proteins may function through dynamic, partial occupancy of the same sites rather than mutually exclusive binding of individual factors.
Recent research has revealed associations between FOXJ3 expression and cancer:
Further comprehensive analysis across various cancer types has identified FOXJ3 as a potential prognostic biomarker in specific cancer types.
Post-translational modifications significantly impact FOXJ3 function in both normal and pathological conditions:
Phosphorylation patterns:
Phosphorylation analysis reveals that the S223 locus of FOXJ3 shows higher phosphorylation levels in breast cancer but decreased levels in pancreatic adenocarcinoma (PAAD) and glioblastoma multiforme (GBM)
The T216 locus shows reduced phosphorylation in clear cell renal cell carcinoma (ccRCC) but increased phosphorylation in lung adenocarcinoma (LUAD) and hepatocellular carcinoma
Functional consequences:
Altered phosphorylation may affect FOXJ3's DNA binding capacity, protein-protein interactions, or subcellular localization
These changes likely contribute to tissue-specific transcriptional programs in different cancer types
The opposing phosphorylation patterns in different cancers suggest context-dependent regulation mechanisms
These findings suggest that FOXJ3 protein phosphorylation at S223 and T216 plays vital roles in cancer development and progression, with different modifications potentially driving distinct pathological outcomes.
While both are members of the FOX family, FOXJ3 and FOXP3 exhibit distinct structural features and functional roles:
Structural differences:
FOXP3 forms a unique head-to-head dimer using a linker (Runx1-binding region, RBR) preceding the forkhead domain
This head-to-head dimerization confers distinct DNA-binding specificity and creates a docking site for the cofactor Runx1
In contrast, FOXJ3 functions through different protein-protein interactions
Immunoregulatory functions:
FOXP3 is the master regulator for regulatory T cell (Treg) development and function
FOXP3 controls immune homeostasis, with mutations causing autoimmune diseases
Cell-permeable FOXP3 can suppress T helper cell differentiation and alleviate experimental autoimmune conditions
In contrast, FOXJ3 has not been directly implicated in immune regulation but rather in tissue development and cellular differentiation
Therapeutic applications:
Protein transduction domain (PTD)-conjugated FOXP3 has been developed as a therapeutic tool for autoimmune conditions
PTD-FOXP3 can block Th1 and Th17 differentiation and attenuate inflammatory conditions
Similar approaches have not yet been reported for FOXJ3, reflecting their different biological roles
The distinct functions of these FOX family members highlight the specialization that has evolved within this transcription factor family despite their structural similarities.
Researchers face several technical challenges when producing recombinant FOXJ3 for structural studies:
Protein solubility and stability issues:
Proper folding considerations:
The RBR linker region is crucial for proper folding of the forkhead domain
Truncation of RBR can induce domain-swap dimerization, which may impair function
Expression systems that facilitate proper folding (such as eukaryotic expression systems) may be preferred over bacterial systems for full-length protein
Purification strategies:
Fusion tags (NusA, 60 kDa) have been used to improve accuracy of molecular weight estimation by SEC-MALS
Multi-step purification approaches combining affinity chromatography, ion exchange, and size exclusion methods are recommended
Careful buffer optimization to maintain protein stability during concentration and storage is essential
These considerations are important for generating functionally relevant FOXJ3 protein for both structural studies and functional assays.
The dynamic nature of FOXJ3 binding during cellular state changes remains an active area of research:
Context-dependent binding patterns:
Cooperative binding with other factors:
Methodological approaches to study dynamic binding:
Time-course ChIP-seq experiments during differentiation or following stress induction
Integration with transcriptome data to correlate binding changes with gene expression
Comparison of binding profiles in different cell types or tissues to identify context-specific binding sites
These dynamics likely contribute to the tissue-specific functions of FOXJ3 in development and disease.
CRISPR-Cas9 technology offers powerful approaches for studying FOXJ3 function:
Design considerations for tissue-specific studies:
Use tissue-specific promoters to drive Cas9 expression
Combine with inducible systems (e.g., Tet-On/Off) for temporal control
Single or multiple guide RNAs targeting different FOXJ3 functional domains can reveal domain-specific functions
Delivery methods for different tissues:
For muscle studies: AAV-mediated delivery or electroporation into skeletal muscle
For reproductive tissue: lentiviral injection into seminiferous tubules
For developmental studies: embryonic delivery or generation of conditional alleles
Functional readouts and validation approaches:
Combine with reporter systems to monitor transcriptional activity of FOXJ3 targets
Validate editing efficiency using targeted sequencing
Confirm functional consequences through analysis of downstream target genes (e.g., Mef2c in muscle, meiotic genes in testes)
Advanced CRISPR applications:
CRISPRa/CRISPRi for modulating FOXJ3 expression without genomic editing
Base editors or prime editors for introducing specific mutations in FOXJ3 binding sites
CRISPR screening to identify FOXJ3 target genes or interaction partners
These approaches can help overcome the limitations of traditional knockout models by providing greater temporal and spatial control of FOXJ3 function.
Several cutting-edge technologies hold promise for elucidating FOXJ3's interactome:
Proximity labeling approaches:
BioID or TurboID fusion proteins to identify proteins in close proximity to FOXJ3 in living cells
APEX2-based proximity labeling for temporal mapping of interactions during cellular processes
These methods can identify weak or transient interactions that may be missed by traditional co-immunoprecipitation
Advanced structural biology techniques:
Cryo-electron microscopy of FOXJ3-containing complexes
Hydrogen-deuterium exchange mass spectrometry (HDX-MS) to map protein interaction surfaces
Integrative structural biology combining NMR, X-ray crystallography, and computational modeling
Single-molecule imaging approaches:
Live-cell imaging of fluorescently tagged FOXJ3 to track dynamic interactions
Single-molecule FRET to study conformational changes upon partner binding
Super-resolution microscopy to visualize FOXJ3 complexes at endogenous loci
These technologies could reveal how FOXJ3 integrates into larger transcriptional complexes and how these interactions are regulated in different cellular contexts.
Therapeutic approaches targeting FOXJ3 function could be developed for specific pathologies:
Potential approaches for muscle disorders:
AAV-mediated delivery of FOXJ3 to enhance muscle regeneration after injury
Small molecule screening to identify compounds that enhance FOXJ3-dependent activation of Mef2c
RNA-based therapeutics (antisense oligonucleotides or siRNA) to modulate FOXJ3 levels in specific fiber types
Strategies for reproductive medicine:
Recombinant FOXJ3 protein delivery systems to support spermatogonial stem cell survival in vitro
Identification of downstream targets that could bypass FOXJ3 deficiency in male infertility
Diagnostic applications to identify FOXJ3 mutations in unexplained male infertility cases
Delivery challenges and solutions:
Tissue-specific targeting strategies using cell-penetrating peptides or nanoparticles
Development of small molecule modulators of FOXJ3 activity through structure-based drug design
Gene therapy approaches using tissue-specific promoters
These potential therapeutic directions require further basic research to fully understand the tissue-specific functions and regulatory mechanisms of FOXJ3.